These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 33976505)
1. 2021 Advocacy Statements for the Role of Huang YH; Lin YH; Yen RF; Hou CJ; Wang SY; Tsai SC; Ho KC; Lin MH; Tsao CH; Chang CY; Huang JL; Cheng MF; Wu YW Acta Cardiol Sin; 2021 May; 37(3):221-231. PubMed ID: 33976505 [TBL] [Abstract][Full Text] [Related]
2. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400 [TBL] [Abstract][Full Text] [Related]
10. The Association of Cardiac Biomarkers, the Intensity of Tc99 Pyrophosphate Uptake, and Survival in Patients Evaluated for Transthyretin Cardiac Amyloidosis in the Early Therapeutics Era. Martyn T; Saef J; Hussain M; Ives L; Kiang A; Estep JD; Collier P; Starling RC; Cremer PC; Tang WHW; Hanna M; Jaber WA J Card Fail; 2022 Oct; 28(10):1509-1518. PubMed ID: 35843490 [TBL] [Abstract][Full Text] [Related]
11. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580 [No Abstract] [Full Text] [Related]
12. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report. Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392 [TBL] [Abstract][Full Text] [Related]
13. Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis. Oike F; Usuku H; Yamamoto E; Marume K; Takashio S; Ishii M; Tabata N; Fujisue K; Yamanaga K; Sueta D; Hanatani S; Arima Y; Araki S; Oda S; Kawano H; Soejima H; Matsushita K; Ueda M; Fukui T; Tsujita K ESC Heart Fail; 2022 Jun; 9(3):1976-1986. PubMed ID: 35338611 [TBL] [Abstract][Full Text] [Related]
14. Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population. Bourque JM; Schepart A; Bhambri R; Castaño A; O'Brien A; Chen Y; Prasad S; Roy A; Grodin JL Am J Cardiol; 2022 Mar; 167():98-103. PubMed ID: 35022130 [TBL] [Abstract][Full Text] [Related]
15. Assessment of cardiac amyloidosis with Ren C; Ren J; Tian Z; Du Y; Hao Z; Zhang Z; Fang W; Li F; Zhang S; Hsu B; Huo L EJNMMI Phys; 2021 Jan; 8(1):3. PubMed ID: 33411102 [TBL] [Abstract][Full Text] [Related]
16. Standardization of Bokhari S; Morgenstern R; Weinberg R; Kinkhabwala M; Panagiotou D; Castano A; DeLuca A; Kontak A; Jin Z; Maurer MS J Nucl Cardiol; 2018 Feb; 25(1):181-190. PubMed ID: 27580616 [TBL] [Abstract][Full Text] [Related]